SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-082799
Filing Date
2023-07-21
Accepted
2023-07-20 17:44:08
Documents
5
Period of Report
2023-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2321494d1_6k.htm 6-K 26763
2 EXHIBIT 1.1 tm2321494d1_ex1-1.htm EX-1.1 327343
3 EXHIBIT 5.1 tm2321494d1_ex5-1.htm EX-5.1 62513
4 EXHIBIT 99.1 tm2321494d1_ex99-1.htm EX-99.1 22151
5 EXHIBIT 99.2 tm2321494d1_ex99-2.htm EX-99.2 21700
  Complete submission text file 0001104659-23-082799.txt   461619
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 231100640
SIC: 2836 Biological Products, (No Diagnostic Substances)